Project

GlycoMASH

GlycoMASH aims to develop a blood test that can detect liver damage before it becomes life-threatening.

Liver fibrosis, often observed in fatty liver disease, progresses silently and affects millions globally. People with type 2 diabetes (T2D) are especially vulnerable, of which 65% have fatty liver disease and around 15% progress to advanced liver fibrosis. Current diagnostic tools are either invasive, inaccurate, or inaccessible, leading to late diagnoses and costly treatments like liver transplants.
Our solution is a non-invasive blood test that detects liver fibrosis at its earliest stage using a novel biomarker- a sugar-based signature found in blood proteins. This test can be performed using blood or dried blood spots, making it scalable and suitable for screening of patients with type 2 diabetes at primary care.

By identifying liver fibrosis early, especially in high-risk groups like T2D patients, we can initiate timely interventions, ranging from lifestyle changes to medication, which will improve patient outcomes. Early detection means fewer hospitalizations and liver transplants, saving millions in long-term care expenses.

Within the Biotech Booster program, we aim to validate the marker in larger clinical cohorts, optimize the test for clinical use, and develop a business and regulatory strategy for integration into routine care.

Project team

Manfred Wuhrer; Katarina Madunic; Marco Bladergroen, Wenjun Wang

Project Number

BIOB25019

Year granted

2025

Status

Ongoing

Applicant

Leiden University Medical Center

Funding

€ 200.000

Sector/Industry

Health & Pharma

SDG's

Good health and well-being (SDG 3)

Thematic Cluster

TC4: Diagnostics and Services

Level

Level 1
Molecuul

2025

Year granted

Leiden University Medical Center

Applicant

€ 200.000

Project funded
Project story

Plant Beams: breaking through the plant barrier

The question that started Plant Beams For over ten years, David Fernández Rivas has worked on a technology that uses

Plant Beams: breaking through the plant barrier
Project story

SideroFORCE: Tricking bacteria to heal infection

We interviewed Wim Velema, projectleader of Biotech Booster project SideroFORCE, which joined our program in 2025. At sixteen, Wim liked

SideroFORCE: Tricking bacteria to heal infection
IBB

Behind the Bootcamp: Meet the IBB26 Coaches

Building an industrial biotech venture takes more than a great scientific idea. It requires the ability to challenge assumptions, make

Behind the Bootcamp: Meet the IBB26 Coaches
Project story

From Luggage Tags to Better Food

From fragmented DNA to better food on our plates. We interviewed Biotech Booster project Haplotagging to learn more about their

From Luggage Tags to Better Food
Impact developer portrait

The Innovation Journey at the Universities of Applied Sciences

Impact Developers help researchers turn their ideas into innovations that impact society. They connect researchers with companies and other partners

The Innovation Journey at the Universities of Applied Sciences
Alumni Column

Alumni column: Patrick Dekker from iProtics

On both sides of the table. Some people know Biotech Booster from the outside. Others experience it from the inside,

Alumni column: Patrick Dekker from iProtics
Citaat

Biotech Booster helps us through funding and by providing us with a network to validate where we can make the best impact with our new analysis device.

Biotechnology netherlands

Carlos de Lannoy

Constellate

Citaat

What we look forward to most is leveraging the extraordinary network of Biotech Booster that we need to get foot in the market, get know-how, and understanding the competitive field which is necessary for setting up successful operations.

Biotechnology netherlands

Pim Schaasberg & Martin Pabst

ProteoT

Moleculen

Newsletter

Receive monthly updates about our community!

Subscribe to our newsletter